Owens & Minor Inc/va/ Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Charles Schwab Investment Management reports a reduction in its beneficial ownership of Accendra Health Inc. to 4.75%.
Kevin M. Webb has filed a Schedule 13G, disclosing beneficial ownership of 5.61% of Accendra Health, Inc.'s common stock.
The Vanguard Group reported a 0% beneficial ownership in Accendra Health Inc. common stock following an internal realignment.
Charles Schwab Investment Management Inc. has reported a 5.24% beneficial ownership stake in Accendra Health Inc., holding over 4 million shares of common stock.
The Vanguard Group has increased its beneficial ownership in Owens & Minor Inc. to 7.71% of common stock, totaling 5,962,847 shares.
SCHEDULE 13G/A: Dimensional Fund Advisors Amends Owens & Minor Stake
Dimensional Fund Advisors LP has filed an amendment to its Schedule 13G, disclosing a 4.5% beneficial ownership stake in Owens & Minor Inc.
BlackRock, Inc. filed an Amendment No. 5 to its Schedule 13G, disclosing a 7.1% beneficial ownership stake in Owens & Minor, Inc. as of September 30, 2025.
Coliseum Capital Management, LLC and its affiliates have filed an amended Schedule 13G, revealing a combined beneficial ownership of 15.1% in Owens & Minor, Inc.'s common stock as of March 31, 2025.
Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have filed an amended Schedule 13G, indicating they no longer beneficially own any shares of Owens & Minor, Inc. common stock as of March 31, 2025.
FMR LLC and Abigail P. Johnson have filed an Amendment No. 5 to their Schedule 13G, reporting a continued passive beneficial ownership of 3.5% in Owens & Minor Inc.'s common stock as of March 31, 2025.
SCHEDULE 13G/A: BlackRock Discloses 14.7% Passive Stake in Owens & Minor Inc.
BlackRock, Inc. has filed an updated Schedule 13G, revealing a passive beneficial ownership of 14.7% in Owens & Minor Inc.'s common stock as of March 31, 2025.
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reaffirming their beneficial ownership of 7.5% of Owens & Minor Inc.'s common stock as of February 28, 2025.
SCHEDULE 13G/A: Coliseum Capital Entities Disclose Significant Stake in Owens & Minor, Inc., Holding Up to 13.8% of Common Stock
Coliseum Capital Management, LLC and its affiliates, including Adam Gray and Christopher Shackelton, have disclosed beneficial ownership of up to 13.8% of Owens & Minor, Inc.'s common stock.